Delivery Order SPE2DB20D3505-SPE2DB23FU2Z7

Award Date 6/21/23
Potential Completion Date 6/22/23
Potential Value $6.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $6,140.12, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Imiquimod 5% Cream Packets, a specialty pharmaceutical product. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This $999,999,999 IDC...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the purchase of IMIQUIMOD 5% CREAM PACKET 24S, a pharmaceutical product, with a ceiling value of $1,127.36 and a period of performance through October 18, 2023. The contract is a firm fixed price, delivery order contract, and there was no set-aside used....
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,890.29, is a delivery order issued by the Defense Logistics Agency (DLA) for the supply of IMIQUIMOD 3.75% CREAM 28S. The contract has a firm fixed price pricing type and an ultimate completion date of February 6, 2025. The award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
This federal contract award, with ID SPE2DB20D1051|SPE2DB25FD6RE, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of IMIQUIMOD 5% CREAM PACKET 24S, with a ceiling value of $6,420.96 and a completion date of January 15, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,004.15, is a delivery order for the supply of IMIQUIMOD 5% CREAM PACKET 24S. It is a firm fixed-price contract with an ultimate completion date of January 30, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $1,568.44 order is for the delivery of IMIQUIMOD 5% CREAM PACKET 24S, a prescription pharmaceutical product, to be provided to DLA Troop Support Medical facilities supporting the Department of Defense. This award is associated with a larger indefinite delivery contract (IDC) held...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,307.81 firm fixed-price delivery order is for the supply of Imiquimod 5% Cream Packets. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, which supports the provision of a broad range of pharmaceutical products and medical supplies to military healthcare...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Imiquimod 5% Cream Packets 24s. The contract, valued at $1,726.61, is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA), a defense agency. The contract has an ultimate completion date of January 15, 2025 and was awarded on January 14, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite...
This federal contract award, SPE2DB22D2007|SPE2DB25FH8PA, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,070.35 Firm Fixed Price delivery order is for the supply of IMIQUIMOD 5% CREAM PACKET 24S medical products. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This federal contract award is a delivery order issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of Imiquimod 3.75% cream, a topical medication, valued at $1,443.24. The award has an ultimate completion date of July 31, 2024 and is a firm fixed-price contract. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA,...
  • SPE2DB20D3505
    Indefinite Delivery Contract
  • SPE2DB20D3505-SPE2DB23FU2Z7
    Delivery Order

This federal contract award, valued at $6,103.36, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of IMIQUIMOD 5% CREAM PACKET 24S, a medical product, with a completion date of June 22, 2023.

The award is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 2/27/25, 11:09 AM